Paclitaxel plus Eftilagimod Alpha, a Soluble LAG-3 Protein, in Metastatic, HR+ Breast Cancer: Results from AIPAC, a Randomized, Placebo Controlled Phase IIb Trial
紫杉醇联合可溶性 LAG-3 蛋白 Eftilagimod Alpha 治疗转移性 HR+ 乳腺癌：AIPAC 随机、安慰剂对照 IIb 期试验的结果
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-23-1173
Wildiers, Hans; Armstrong, Anne; Cuypere, Eveline; Dalenc, Florence; Dirix, Luc; Chan, Steve; Marme, Frederik; Schröder, Carolina P; Huober, Jens; Duhoux, Francois P; Vuylsteke, Peter; Jager, Agnes; Brain, Etienne; Kuemmel, Sherko; Pápai, Zsuzsanna; Menke-van der Houven van Oordt, Catharina Willemien; Perjesi, Luca; Mueller, Christian; Brignone, Chrystelle; Triebel, Frederic
